| Price | 1,340.00p on 17-06-2026 at 15:55:11 |
|---|---|
| Change | 48.00p 3.72% |
| Buy | 1,346.00p |
| Sell | 1,340.00p |
| Last Trade: | Buy 3,501.00 at 1,340.00p |
| Day's Volume: | 37,750 |
| Last Close: | 1,340.00p |
| Open: | 1,300.00p |
| ISIN: | GB0000385517 |
| Day's Range | 1,300.00p - 1,346.00p |
| 52wk Range: | 702.00p - 1,374.00p |
| Market Capitalisation: | £258.80m |
| VWAP: | 1,320.45262p |
| Shares in Issue: | 19.31m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Biotech Gwth (BIOG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 3,501 | 1,340.00p | Suspected BUY Trade |
16:35:21 - 17-Jun-26 |
| Buy* | 436 | 1,343.12p | Ordinary |
16:29:30 - 17-Jun-26 |
| Sell* | 4 | 1,340.00p | SI Trade |
16:29:30 - 17-Jun-26 |
| Buy* | 211 | 1,346.00p | Automatic Execution |
16:28:14 - 17-Jun-26 |
| Buy* | 189 | 1,342.00p | Automatic Execution |
16:28:14 - 17-Jun-26 |
| Buy* | 74 | 1,342.00p | Automatic Execution |
16:28:14 - 17-Jun-26 |
| Buy* | 123 | 1,346.00p | Automatic Execution |
16:25:43 - 17-Jun-26 |
| Buy* | 82 | 1,344.00p | Automatic Execution |
16:25:40 - 17-Jun-26 |
| Sell* | 101 | 1,336.00p | Automatic Execution |
16:17:21 - 17-Jun-26 |
| Buy* | 190 | 1,338.00p | Automatic Execution |
16:17:09 - 17-Jun-26 |
Biotech Gwth (BIOG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Jun 2026 12:48 pm | PRN | Net Asset Value(s) |
| 15th Jun 2026 12:43 pm | PRN | Net Asset Value(s) |
| 12th Jun 2026 5:39 pm | PRN | Transaction in Own Shares |
| 12th Jun 2026 3:48 pm | PRN | Net Asset Value(s) |
| 11th Jun 2026 1:32 pm | PRN | Net Asset Value(s) |
| 10th Jun 2026 3:07 pm | PRN | Monthly Fact Sheet as at 31 May 2026 |
| 10th Jun 2026 1:33 pm | PRN | Net Asset Value(s) |
| 9th Jun 2026 1:57 pm | PRN | GSK plc to acquire BIOG portfolio company, Nuvalent, Inc. |
| 9th Jun 2026 12:47 pm | PRN | Net Asset Value(s) |
| 8th Jun 2026 1:58 pm | PRN | Net Asset Value(s) |
